Developer docs
API playgroundTry for free, no card

Search company profiles

ELM Group

Full company profile

uuid000hjfm

Namestring
ELM Group
Legal namestring
ELM Group (Stafford) Ltd
Websiteurl
elmgroupltd.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

ELM Group (Stafford) Ltd is a UK-based private holding company founded in 2014 by Martin Lennon in Stafford, operating three integrated divisions: ELM Medical (medical communications and strategic support), ELM Digital (proprietary digital platforms and web solutions), and CESAS Medical (independent medical education). The firm delivers bespoke medical communications services including advisory boards, symposia, publications, strategic planning, and integrated evidence planning for global pharmaceutical clients such as Pfizer, Lilly, AstraZeneca, GSK, AbbVie, Sanofi, BioMarin, Shionogi, Gilead, Boehringer Ingelheim, and Norgine, with additional engagements for academic institutions including the University of Glasgow and University of Leeds.

The technology backbone is the HALO Suite under ELM Digital, comprising HORUS (a specialized search engine aggregating drug and disease area data from PubMed and ClinicalTrials.gov), ATHENA (an AI-augmented expert mapping platform using publication and citation metrics), LYNX (a secure web-based forum for global expert consultation), and ORION (an engagement tracking platform), delivered through the .expert platform network. CESAS Medical runs four therapy-area educational forums — IMID Forum (University of Glasgow), Lupus Forum and Scleroderma Forum (University of Leeds), and the International Achondroplasia Forum — collectively engaging over 20,000 HCP members and overseen by world-renowned Steering Committees.

The business model is predominantly professional services with bespoke, project-based pricing supplemented by platform licensing. Revenue is generated through three streams: medical communications services for pharma clients, digital platform licensing (HORUS, ATHENA, LYNX, ORION, .expert sites), and independent medical education funded via educational grants. Operations span 50+ countries across 6 continents, with offices in Stafford (HQ) and Edinburgh, and a team of approximately 25-35 people including a leadership bench with 25-30+ years of pharmaceutical industry experience.

Short descriptiontext

ELM Group is a UK-based private holding company operating ELM Medical, ELM Digital, and CESAS Medical, delivering bespoke medical communications, proprietary expert-engagement platforms (HALO Suite), and independent medical education to global pharmaceutical companies and academic institutions.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersStafford, United Kingdom
HQ citystring
Stafford
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical communications, independent medical education, expert engagement platforms, key opinion leader mapping, pharmaceutical advisory services
Industry1 code
PRIMARYTHAHACAI
Speaker, Program & Abstract Management Services
Travel & Hospitality/MICE (Meetings, Incentives, Conferences & Exhibitions)/Professional Conference Organizers (PCOs) & Meeting Planners
NAICS code2 codes
  • Professional Organizations813920
  • Educational Support Services6117
SIC code2 codes
  • Services-Membership Organizations8600
  • Services-Health Services8000
Product category
Medical Communications Services
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Communications Services
TypeProfessional Services
Description

Project-based professional services for medical communications including advisory boards, symposia, publications, strategic planning, and integrated evidence planning for pharmaceutical clients.

2Digital Platform Services
TypeLicensing Royalties
Description

Licensing and support for proprietary digital platforms including .expert websites, HORUS, ATHENA, LYNX, and ORION for expert engagement and content management.

3Independent Medical Education
TypeProfessional Services
Description

Development and delivery of independent medical education programmes for healthcare professionals, funded through educational grants from pharmaceutical companies.

elmgroupltd.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 6 records shown
1.expert Platform
Description

Online platform providing HCPs with educational resources including modules, monthly publication reviews, congress highlights, live webinars, and podcasts.

elmgroupltd.com
+5 more records
Core offering1 text field

ELM Group provides bespoke medical communications, independent medical education, and proprietary digital platform solutions for global pharmaceutical companies and academic institutions. Through its three operating divisions—ELM Medical, ELM Digital, and CESAS Medical—it delivers advisory boards, symposia, publications, KOL mapping, educational programs, and digital engagement platforms covering specialized therapeutic areas including immune-mediated inflammatory diseases, lupus, achondroplasia, and scleroderma.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 20,000+ healthcare professionals engaged through educational platforms
+2 more records
Product overview1 text field

ELM Group is a medical communications company operating as a platform of interconnected divisions and products. The core offering consists of ELM Medical (strategic medical communications and programme delivery), ELM Digital (digital platforms and solutions), and CESAS Medical (independent medical education). ELM Digital's HALO Suite comprises HORUS (drug/disease search engine), ATHENA (AI-augmented expert mapping), LYNX (expert consultation forum), and ORION (engagement tracking), all accessible via the .expert platform. CESAS Medical hosts four award-winning educational forums (IMID Forum, Lupus Forum, IAF, Scleroderma Forum) serving over 20,000 members. The products integrate to provide a comprehensive ecosystem for medical education, expert engagement, and scientific communication.

Product and service13 records
1HALO Suite
CategoryDigital Platform Suite
2HORUS
CategorySearch and Intelligence Platform
3ATHENA
CategoryExpert Mapping Platform
4LYNX
CategoryExpert Consultation Platform
5ORION
CategoryEngagement Tracking Platform
6.expert Educational Platform Network
CategoryIndependent Medical Education Platform
7IMID Forum (Immune-Mediated Inflammatory Disease Forum)
CategoryIndependent Medical Education Platform
8Lupus Forum
CategoryIndependent Medical Education Platform
9International Achondroplasia Forum (IAF)
CategoryIndependent Medical Education Platform
10Scleroderma Forum
CategoryIndependent Medical Education Platform
11ELM Medical Communications Services
CategoryMedical Communications Services
12CESAS Medical Independent Education Services
CategoryIndependent Medical Education Services
Description

Independent medical education services developing high-quality educational programmes for healthcare professionals using world-leading faculty from renowned academic institutions, including the four .expert educational platforms and the inaugural European Achondroplasia Forum conference.

13ELM Digital Platform Development Services
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
1European Achondroplasia Forum (EAF)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

CESAS Medical supported EAF in developing consensus-based guiding principles for achondroplasia care and hosted the inaugural European achondroplasia conference in 2023, the first ever conference dedicated to achondroplasia in Europe.

elmgroupltd.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

IMID Forum (Immune-Mediated Inflammatory Disease Forum) developed under the auspices of the University of Glasgow, providing continuing medical education with academic oversight and rigour.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Lupus Forum and Scleroderma Forum developed under the auspices of the University of Leeds, providing independent medical education with university academic oversight.

Strategic tierMajorTypeOthers
Description

Long-standing pharmaceutical partner for medical communications and educational programme development.

Strategic tierMajorTypeOthers
Description

Pharmaceutical partner for medical communications and programme development.

Strategic tierMajorTypeOthers
Description

Pharmaceutical partner for medical education and communications.

Strategic tierMajorTypeOthers
Description

Pharmaceutical partner for programme development.

Strategic tierMajorTypeOthers
Description

Pharmaceutical partner for educational programme development.

Strategic tierMajorTypeOthers
Description

Pharmaceutical partner for programme development.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Bollington, UK-based global medical communications and health insights group with capabilities spanning medical affairs, publications, and expert engagement. Overlaps directly with ELM's combination of medical communications, KOL engagement, and digital platforms.

TypeDirect peer
Description

UK-headquartered medical communications and behaviour-change agency supporting global pharma across product lifecycles. Directly comparable to ELM Medical in services (medical communications, advisory boards, symposia) and target buyers (enterprise pharma).

TypeDirect peer
Description

Marlow, UK-headquartered global medical communications and health economics group serving pharma and biotech. Comparable in client base, scope of services (medical communications, HEOR, patient engagement), and event-driven GTM.

TypeBroad incumbent
Description

Medical communications arm of IQVIA, the world's largest CRO. Comparable in offering medical communications, KOL engagement, and scientific content at large pharma, but as part of a much broader CRO/IQVIA portfolio spanning clinical, real-world evidence, and commercial services.

TypeBroad incumbent
Description

Global pharma services group (formed from Huntsworth/Ashfield combination) with sizable medical communications capability. Overlaps with ELM in pharma advisory board management and medical education but operates at significantly larger scale.

TypeBroad incumbent
Description

Global health and wellness communications network within Havas. Adjacent in pharma medical communications and HCP engagement, but provides a much broader portfolio across advertising, PR, and digital.

TypeBroad incumbent
Description

US-headquartered health communications and data-driven marketing agency serving pharma. Overlaps in KOL identification, HCP engagement, and integrated medical communications, though with a much larger communications/marketing portfolio.

TypeDirect peer
Description

UK-based healthcare consulting and communications firm with capabilities in KOL engagement, market access, and medical communications. Comparable client base (global pharma) and medcomms service scope.

TypeBroad incumbent
Description

Part of the Inizio Health group, Ashfield Health is a large global pharma-services agency offering medical affairs, advisory board management, and digital engagement. Overlaps with ELM's pharma-services offering but at significantly larger scale and broader service portfolio.

TypeDirect peer
Description

Oxford, UK-based independent medical communications agency with strong publication-planning and health economics focus. Directly comparable in independent MedComms positioning and academic-affiliated content credibility.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks1 record

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers15 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability1 record

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ELM Group

Medical Communications Serviceselmgroupltd.com

ELM Group is a UK-based private holding company operating ELM Medical, ELM Digital, and CESAS Medical, delivering bespoke medical communications, proprietary expert-engagement platforms (HALO Suite), and independent medical education to global pharmaceutical companies and academic institutions.

What ELM Group does

ELM Group (Stafford) Ltd is a UK-based private holding company founded in 2014 by Martin Lennon in Stafford, operating three integrated divisions: ELM Medical (medical communications and strategic support), ELM Digital (proprietary digital platforms and web solutions), and CESAS Medical (independent medical education). The firm delivers bespoke medical communications services including advisory boards, symposia, publications, strategic planning, and integrated evidence planning for global pharmaceutical clients such as Pfizer, Lilly, AstraZeneca, GSK, AbbVie, Sanofi, BioMarin, Shionogi, Gilead, Boehringer Ingelheim, and Norgine, with additional engagements for academic institutions including the University of Glasgow and University of Leeds.

The technology backbone is the HALO Suite under ELM Digital, comprising HORUS (a specialized search engine aggregating drug and disease area data from PubMed and ClinicalTrials.gov), ATHENA (an AI-augmented expert mapping platform using publication and citation metrics), LYNX (a secure web-based forum for global expert consultation), and ORION (an engagement tracking platform), delivered through the .expert platform network. CESAS Medical runs four therapy-area educational forums — IMID Forum (University of Glasgow), Lupus Forum and Scleroderma Forum (University of Leeds), and the International Achondroplasia Forum — collectively engaging over 20,000 HCP members and overseen by world-renowned Steering Committees.

The business model is predominantly professional services with bespoke, project-based pricing supplemented by platform licensing. Revenue is generated through three streams: medical communications services for pharma clients, digital platform licensing (HORUS, ATHENA, LYNX, ORION, .expert sites), and independent medical education funded via educational grants. Operations span 50+ countries across 6 continents, with offices in Stafford (HQ) and Edinburgh, and a team of approximately 25-35 people including a leadership bench with 25-30+ years of pharmaceutical industry experience.

ELM Group firmographics

Firmographics
Name
ELM Group
Legal name
ELM Group (Stafford) Ltd
Website
https://elmgroupltd.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
11–50 employees
Short description
ELM Group is a UK-based private holding company operating ELM Medical, ELM Digital, and CESAS Medical, delivering bespoke medical communications, proprietary expert-engagement platforms (HALO Suite), and independent medical education to global pharmaceutical companies and academic institutions.
Ownership category
akta.pro rank

ELM Group industry classification

Industry
Product category
Medical Communications Services
NAICS
Professional Organizations (813920), Educational Support Services (6117)
SIC
Services-Membership Organizations (8600), Services-Health Services (8000)
akta.pro industry
PRIMARYTHAHACAI
Speaker, Program & Abstract Management Services
Travel & Hospitality/MICE (Meetings, Incentives, Conferences & Exhibitions)/Professional Conference Organizers (PCOs) & Meeting Planners

Keywords

  • Medical communications
  • Independent medical education
  • Expert engagement platforms
  • Key opinion leader mapping
  • Pharmaceutical advisory services

Where ELM Group is headquartered

Location

Headquarters

HQ city
Stafford
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

ELM Group business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Medical Communications Services: Project-based professional services for medical communications including advisory boards, symposia, publications, strategic planning, and integrated evidence planning for pharmaceutical clients.
  2. Digital Platform Services: Licensing and support for proprietary digital platforms including .expert websites, HORUS, ATHENA, LYNX, and ORION for expert engagement and content management.
  3. Independent Medical Education: Development and delivery of independent medical education programmes for healthcare professionals, funded through educational grants from pharmaceutical companies.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

ELM Group product offering

Product offering

Core offering

ELM Group provides bespoke medical communications, independent medical education, and proprietary digital platform solutions for global pharmaceutical companies and academic institutions. Through its three operating divisions—ELM Medical, ELM Digital, and CESAS Medical—it delivers advisory boards, symposia, publications, KOL mapping, educational programs, and digital engagement platforms covering specialized therapeutic areas including immune-mediated inflammatory diseases, lupus, achondroplasia, and scleroderma.

Product overview

ELM Group is a medical communications company operating as a platform of interconnected divisions and products. The core offering consists of ELM Medical (strategic medical communications and programme delivery), ELM Digital (digital platforms and solutions), and CESAS Medical (independent medical education). ELM Digital's HALO Suite comprises HORUS (drug/disease search engine), ATHENA (AI-augmented expert mapping), LYNX (expert consultation forum), and ORION (engagement tracking), all accessible via the .expert platform. CESAS Medical hosts four award-winning educational forums (IMID Forum, Lupus Forum, IAF, Scleroderma Forum) serving over 20,000 members. The products integrate to provide a comprehensive ecosystem for medical education, expert engagement, and scientific communication.

Differentiator

Problem solved

Functional benefit

Brands

  • .expert Platform: Online platform providing HCPs with educational resources including modules, monthly publication reviews, congress highlights, live webinars, and podcasts.
  • HALO Suite
  • HORUS
  • ATHENA
  • LYNX
  • ORION

Products and services

  • HALO Suite
  • HORUS
  • ATHENA
  • LYNX
  • ORION
  • .expert Educational Platform Network
  • IMID Forum (Immune-Mediated Inflammatory Disease Forum)
  • Lupus Forum
  • International Achondroplasia Forum (IAF)
  • Scleroderma Forum
  • ELM Medical Communications Services
  • CESAS Medical Independent Education Services Independent medical education services developing high-quality educational programmes for healthcare professionals using world-leading faculty from renowned academic institutions, including the four .expert educational platforms and the inaugural European Achondroplasia Forum conference.
  • ELM Digital Platform Development Services

Quantifiable outcome

  • 20,000+ healthcare professionals engaged through educational platforms
  • +2 more outcomes

Companies that use ELM Group

Customer profile

Named customers15 records

Segments4 records

Ideal customer profiles3 records

ELM Group technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature6 records

ELM Group partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and major.

  • European Achondroplasia Forum (EAF)coreStrategic or Co-development Partner · 1 January 2023CESAS Medical supported EAF in developing consensus-based guiding principles for achondroplasia care and hosted the inaugural European achondroplasia conference in 2023, the first ever conference dedicated to achondroplasia in Europe.
  • University of GlasgowcoreStrategic or Co-development PartnerIMID Forum (Immune-Mediated Inflammatory Disease Forum) developed under the auspices of the University of Glasgow, providing continuing medical education with academic oversight and rigour.
  • University of LeedscoreStrategic or Co-development PartnerLupus Forum and Scleroderma Forum developed under the auspices of the University of Leeds, providing independent medical education with university academic oversight.
  • PfizermajorOthersLong-standing pharmaceutical partner for medical communications and educational programme development.
  • LillymajorOthersPharmaceutical partner for medical communications and programme development.
  • AbbViemajorOthersPharmaceutical partner for medical education and communications.
  • AstraZenecamajorOthersPharmaceutical partner for programme development.
  • GSKmajorOthersPharmaceutical partner for educational programme development.
  • SanofimajorOthersPharmaceutical partner for programme development.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

ELM Group competitors and assessment

Company assessment

Direct peers

  • Fishawack Health: Bollington, UK-based global medical communications and health insights group with capabilities spanning medical affairs, publications, and expert engagement. Overlaps directly with ELM's combination of medical communications, KOL engagement, and digital platforms.
  • Lucid Group: UK-headquartered medical communications and behaviour-change agency supporting global pharma across product lifecycles. Directly comparable to ELM Medical in services (medical communications, advisory boards, symposia) and target buyers (enterprise pharma).
  • OPEN Health: Marlow, UK-headquartered global medical communications and health economics group serving pharma and biotech. Comparable in client base, scope of services (medical communications, HEOR, patient engagement), and event-driven GTM.
  • Cello Health: UK-based healthcare consulting and communications firm with capabilities in KOL engagement, market access, and medical communications. Comparable client base (global pharma) and medcomms service scope.
  • Oxford PharmaGenesis: Oxford, UK-based independent medical communications agency with strong publication-planning and health economics focus. Directly comparable in independent MedComms positioning and academic-affiliated content credibility.

Broad incumbents

  • IQVIA Medical Communications: Medical communications arm of IQVIA, the world's largest CRO. Comparable in offering medical communications, KOL engagement, and scientific content at large pharma, but as part of a much broader CRO/IQVIA portfolio spanning clinical, real-world evidence, and commercial services.
  • Inizio Medical: Global pharma services group (formed from Huntsworth/Ashfield combination) with sizable medical communications capability. Overlaps with ELM in pharma advisory board management and medical education but operates at significantly larger scale.
  • Havas Health & You: Global health and wellness communications network within Havas. Adjacent in pharma medical communications and HCP engagement, but provides a much broader portfolio across advertising, PR, and digital.
  • Real Chemistry: US-headquartered health communications and data-driven marketing agency serving pharma. Overlaps in KOL identification, HCP engagement, and integrated medical communications, though with a much larger communications/marketing portfolio.
  • Ashfield Health: Part of the Inizio Health group, Ashfield Health is a large global pharma-services agency offering medical affairs, advisory board management, and digital engagement. Overlaps with ELM's pharma-services offering but at significantly larger scale and broader service portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks1 record

Key highlights7 records

Customer concentration

ELM Group social profiles

Digital presence

ELM Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ELM Group leadership team

Management profile

Number of profiles

Profiles7 records

ELM Group subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

ELM Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ELM Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ELM Group

What does ELM Group do?

ELM Group provides bespoke medical communications, independent medical education, and proprietary digital platform solutions for global pharmaceutical companies and academic institutions. Through its three operating divisions—ELM Medical, ELM Digital, and CESAS Medical—it delivers advisory boards, symposia, publications, KOL mapping, educational programs, and digital engagement platforms covering specialized therapeutic areas including immune-mediated inflammatory diseases, lupus, achondroplasia, and scleroderma.

Is ELM Group a public or private company?

ELM Group is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was ELM Group founded?

ELM Group was founded in 2014. It employs 11 to 50 people.

Where is ELM Group based?

ELM Group is headquartered in Stafford, United Kingdom, in the Europe region.

How does ELM Group make money?

Three revenue lines are on record. Medical Communications Services are the primary driver. The others are digital Platform Services and independent Medical Education.

Who are ELM Group's main competitors?

Direct peers on record are Fishawack Health, Lucid Group, OPEN Health, Cello Health and Oxford PharmaGenesis. Broad incumbents are IQVIA Medical Communications, Inizio Medical, Havas Health & You, Real Chemistry and Ashfield Health.

Does ELM Group have an API?

No public API is recorded for ELM Group.

What industry is ELM Group in?

ELM Group's product category is Medical Communications Services. Its primary akta.pro industry code is THAHACAI, Speaker, Program & Abstract Management Services. Its NAICS code is 813920 and its SIC code is 8600.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales